Anita Brikman: There Are Countless More Individuals Who Would Benefit from Access to Plasma-Derived Medicines
Anita Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”As International Plasma Awareness Week comes to a close, I’m grateful to all who supported the incredible efforts to recognize the lifesaving power of plasma and plasma donors. It was truly moving to see how Plasma Powers Possibility for so many around the globe.
But it is also clear that our mission doesn’t stop here. There are countless more individuals who would benefit from access to plasma-derived medicines, especially those in lower and middle income countries where the availability of treatment for rare diseases is limited at best.
The Plasma Protein Therapeutics Association (PPTA) efforts around awareness, advocacy, and access will continue on a daily basis. Because in reality, every week should be an awareness week filled with opportunities to reach out and educate. Pictured below are some of our awareness and activities from IPAW2025 including a powerful patient webinar, a Brussels panel on the Critical Medicines Act, a moving patient and donor meeting with GBS|CIDP Foundation International, and just one of the many patient testimonials we received over the last few days.
Next week, the momentum continues at the Plasma Protein Forum, where industry leaders, health care providers, and patient advocates will come together to advance innovation and address timely issues that impact the entire plasma community.
There’s still time to register, and I hope to see many of you there.
Visit the forum for more details on next week’s gathering.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 11:29Jigesha Dholakia: Supporting the Hemophilia Community Through the Unite Walk
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient